Crohn's patients surviving longer, overtreatment in spotlight 22 Feb 2012 0 comments Australian Crohn’s disease patients live about as long as the general population, avoiding the 1.5 fold increased mortality found among their counterparts in other countries, according to data presented at ECCO Congress in Barcelona this week.
Anti-TNF beats thiopurines in post-op CD 22 Feb 2012 0 comments Adalimumab appears to be more effective than thiopurines for preventing Crohn’s disease recurrence after ileocecal resection, according to early results from the first trial prospectively comparing the two therapies.
What causes Crohn’s? Aussie GEs lead the way 22 Feb 2012 0 comments Australian gastroenterologists are leading the way with a promising approach to discovering the causes of Crohn’s disease, taking advantage of a unique natural experiment.
Australian women need more IBD-pregnancy info 22 Feb 2012 0 comments Better education is needed for Australian women with IBD since almost 50% of those at child-bearing age have poor knowledge of pregnancy-related issues in IBD, conclude the authors of a UK and Australian study presented in a poster at ECCO in Barcelona.
Bran and starch potential therapies for UC in remission 22 Feb 2012 0 comments Wheat bran and resistant starch may be cheap and effective new therapies for UC patients in remission, a small but promising Australian study presented at ECCO suggests.
FODMAPS implicated in active IBD 22 Feb 2012 0 comments Patients with active IBD tend to consume more FODMAPs and fibre than their counterparts with inactive IBD, suggesting the patients’ diet may contribute to their symptoms, an Australian study presented at ECCO suggests.